Multimodality magnetic resonance imaging of prostate cancer

Journal of Endourology

Volumn 24, Issue 5, 2010, Pages 677-684

  Engelbrecht, Marc R ^a   Puech, Philippe ^b,c,d   Colin, Pierre ^b,c,d   Akin, Oguz ^e   Lemaître, Laurent ^b,c   Villers, Arnauld ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER STAGING; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HORMONAL THERAPY; HUMAN; IMAGING AND DISPLAY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; RADIODIAGNOSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STANDARDIZATION; TUMOR VOLUME;

EID: 77952561796     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0597     Document Type: Review

References (45)

1. Stamey TA, CaldwellM,McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? J Urol 2004;172:1297-1301.
2. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: Identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008;246:480-488.
3. deSouza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: A potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008;63:774-782.
4. Kumar R, Nayyar R, Kumar V, et al. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng=ml: A follow-up study. Urology 2008;72:859-863.
5. Casciani E, Polettini E, Carmenini E, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008;190:1187-1192.
6. Kirkham AP, Emberton M, Hoh IM, et al. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 2008;246:833-844.
7. Haider MA, Chung P, Sweet J, et al. Dynamic contrastenhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:425-430.
8. Bouyé S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009;69:105-113.
9. Haffner J, Potiron E, Bouyé S, et al. Peripheral zone prostate cancers: Location and intraprostatic patterns of spread at histopathology. Prostate 2009;69:276-282.
10. Wang L, Zhang J, Schwartz LH, et al. Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. AJR Am J Roentgenol 2007;188:99-104.
11. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: Features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239:784-792.
12. Mullerad M, Hricak H, Wang L, et al. Prostate cancer: Detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 2004;232:140-146.
13. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241:449-458.
14. Girouin N,Mége-Lechevallier F, Tonina Senes A, et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: Is it reasonable? Eur Radiol 2007;17:1498-1509.
15. Puech P, Potiron E, Lemaitre L, et al. Dynamic contrastenhanced- magnetic resonance imaging evaluation of intraprostatic prostate cancer: Correlation with radical prostatectomy specimens. Urology 2009;74:1094-1099.
16. Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol 2006;176:2432-2437.
17. Yu JS, Chung JJ, Hong SW, et al. Prostate cancer: Added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil. Yonsei Med J 2008;49:765-774.
18. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254.
19. Haider MA, Van Der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007;189:323-328.
20. Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: Comparison of diffusion-weighted and T2- weighted imaging. Eur J Radiol 2007;61:297-302.
21. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: Apparent diffusion coefficient map with T2-weighted images for detection- a multireader study. Radiology 2009;250:145-151.
22. Park BK, Lee HM, Kim CK, et al. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 2008;43:789-793.
23. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology. J Magn Reson Imaging 2008;27:132-139.
24. Yoshizako T, Wada A, Hayashi T, et al. Usefulness of diffusion- weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008;49:1207-1213.
25. Chen M, Dang HD, Wang JY, et al. Prostate cancer detection: Comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008;49:602-610.
26. Kajihara H, Hayashida Y, Murakami R, et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:399-403.
27. deSouza NM, Reinsberg SA, Scurr ED, et al. Magnetic resonance imaging in prostate cancer: The value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007;80:90-95.
28. Zelhof B, Pickles M, Liney G, et al. Correlation of diffusionweighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009;103:883-888.
29. Langer DL, Van Der Kwast TH, Evans AJ, et al. Intermixed normal tissue within prostate cancer: Effect on MR imaging measurements of apparent diffusion coefficient and T2- sparse versus dense cancers. Radiology 2008;249:900-908.
30. Gürses B, Kabakci N, Kovanlikaya A, et al. Diffusion tensor imaging of the normal prostate at 3 Tesla. Eur Radiol 2008;18:716-721.
31. Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol 2007;42:412-419.
32. Morakkabati-Spitz N, Bastian PJ, Gieseke J, et al. MR imaging of the prostate at 3.0T with external phased array coil-preliminary results. Eur J Med Res 2008;13:287-291
33. Carlani M, Mancino S, Bonanno E, et al. Combined morphological, [1H]-MRspectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: Preliminary experience. Radiol Med (Torino), 2008;113:670-688.
34. Villeirs GM, Oosterlinck W, Vanherreweghe E, De Meerleer GO. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur J Radiol 2008, Dec 10. Epub ahead of print.
35. Westphalen AC, Coakley FV, Qayyum A, et al. Peripheral zone prostate cancer: Accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology 2008;246:177-184.
36. Wang P, Guo YM, Liu M, et al. A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool. Korean J Radiol 2008;9:432-438.
37. Umbehr M, Bachmann LM, Held U, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: A systematic review and meta-analysis. Eur Urol 2009;55:575-590.
38. Puech P, Huglo D, Petyt G, et al. Imaging of organ-confined prostate cancer: Functional ultrasound, MRI and PET=comcomputed tomography. Curr Opin Urol 2009;19:168-176.
39. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: Present and future. Curr Opin Urol 2008;18:71-77.
40. Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589-600.
41. Tamada T, Sone T, Jo Y, et al. Prostate cancer: Relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008;248:531-539.
42. Prando A, Prostate cancer: Identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Int Braz J Urol 2008;34:105-106.
43. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007;188:91-98.
44. Kim CK, Park BK. Update of prostate magnetic resonance imaging at 3 T. J Comput Assist Tomogr 2008;32:163-172.
45. Park BK, Kim B, Kim CK, et al. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer. J Comput Assist Tomogr 2007;31:534-538.